These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 5154876)

  • 61. Analysis of the hemagglutination activity domains of the Venezuelan equine encephalomyelitis and eastern equine encephalomyelitis viruses.
    Razumov IA; Khusainova AD; Agapov EV; Gaidamovich SYa ; Pereboev AV; Kolykhalov AA; Netesov SV; Loktev VB
    Intervirology; 1994; 37(6):356-60. PubMed ID: 8586535
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Genetically engineered, live, attenuated vaccines protect nonhuman primates against aerosol challenge with a virulent IE strain of Venezuelan equine encephalitis virus.
    Reed DS; Lind CM; Lackemeyer MG; Sullivan LJ; Pratt WD; Parker MD
    Vaccine; 2005 May; 23(24):3139-47. PubMed ID: 15837213
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Self-Amplifying RNA Vaccines for Venezuelan Equine Encephalitis Virus Induce Robust Protective Immunogenicity in Mice.
    Samsa MM; Dupuy LC; Beard CW; Six CM; Schmaljohn CS; Mason PW; Geall AJ; Ulmer JB; Yu D
    Mol Ther; 2019 Apr; 27(4):850-865. PubMed ID: 30770173
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Venezuelan and western equine encephalitis virus E1 liposome antigen nucleic acid complexes protect mice from lethal challenge with multiple alphaviruses.
    Rico AB; Phillips AT; Schountz T; Jarvis DL; Tjalkens RB; Powers AM; Olson KE
    Virology; 2016 Dec; 499():30-39. PubMed ID: 27632563
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Host immune responses after administration of inactivated Venezuelan equine encephalomyelitis virus vaccines. I. Description and characterization of adoptive transfer by immune spleen cells.
    Rabinowitz SG
    J Infect Dis; 1976 Jul; 134(1):30-8. PubMed ID: 939921
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Interaction of alphaviruses with human peripheral leukocytes: in vitro replication of Venezuelan equine encephalomyelitis virus in monocyte cultures.
    Levitt NH; Miller HV; Edelman R
    Infect Immun; 1979 Jun; 24(3):642-6. PubMed ID: 468371
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Long-term duration of detectable neutralizing antibodies after administration of live-attenuated VEE vaccine and following booster vaccination with inactivated VEE vaccine.
    Pittman PR; Makuch RS; Mangiafico JA; Cannon TL; Gibbs PH; Peters CJ
    Vaccine; 1996 Mar; 14(4):337-43. PubMed ID: 8744562
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Experimental infection of horses with an attenuated Venezuelan equine encephalomyelitis vaccine (strain TC-83).
    Walton TE; Alvarez O; Buckwalter RM; Johnson KM
    Infect Immun; 1972 May; 5(5):750-6. PubMed ID: 4637604
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Serological survey on arbovirus infection in residents of an ecological reserve].
    Romano-Lieber NS; Iversson LB
    Rev Saude Publica; 2000 Jun; 34(3):236-42. PubMed ID: 10920445
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Sequential immunization procedure against Group B arboviruses using living attenuated 17D yellow fever virus, living attenuated Langat E5 virus, and living attenuated dengue 2 virus (New Guinea C isolate).
    Price WH; Casals J; Thind I; O'Leary W
    Am J Trop Med Hyg; 1973 Jul; 22(4):509-23. PubMed ID: 4352231
    [No Abstract]   [Full Text] [Related]  

  • 71. Venezuelan equine encephalitis virus vaccine candidate (V3526) safety, immunogenicity and efficacy in horses.
    Fine DL; Roberts BA; Teehee ML; Terpening SJ; Kelly CL; Raetz JL; Baker DC; Powers AM; Bowen RA
    Vaccine; 2007 Feb; 25(10):1868-76. PubMed ID: 17240002
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [EPIDEMIOLOGIC ANALYSIS OF OUTBREAKS OF DISEASES CAUSED BY AMERICAN EQUINE ENCEPHALITIS CAUSATIVE AGENTS IN ENDEMIC REGIONS].
    Petrov AA; Lebedev VN; Kulish VS; Pyshnaya NS; Stovba LF; Borisevich SV
    Zh Mikrobiol Epidemiol Immunobiol; 2015; (5):103-10. PubMed ID: 26829861
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Arbovirus surveillance in six states during 1972.
    Hayes RO; Francy DB; Lazuick JS; Smith GC; Jones RH
    Am J Trop Med Hyg; 1976 May; 25(3):463-76. PubMed ID: 7148
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Limited potential for mosquito transmission of genetically engineered, live-attenuated western equine encephalitis virus vaccine candidates.
    Turell MJ; O'Guinn ML; Parker MD
    Am J Trop Med Hyg; 2003 Feb; 68(2):218-21. PubMed ID: 12641414
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Inhibitors of Western and Venezuelan equine encephalitis viruses in cattle sera from Hawaii.
    Scherer WF; Reeves WC; Hardy JL; Miura T
    Am J Trop Med Hyg; 1972 Mar; 21(2):189-93. PubMed ID: 5061277
    [No Abstract]   [Full Text] [Related]  

  • 76. Cross-protection among viruses of the Venezuelan equine encephalitis complex in hamsters.
    Scherer WF; Pancake BA
    Am J Epidemiol; 1970 Feb; 91(2):225-9. PubMed ID: 5416252
    [No Abstract]   [Full Text] [Related]  

  • 77. Specificity of immunoglobulin M and G antibody responses in humans infected with eastern and western equine encephalitis viruses: application to rapid serodiagnosis.
    Calisher CH; Berardi VP; Muth DJ; Buff EE
    J Clin Microbiol; 1986 Feb; 23(2):369-72. PubMed ID: 3009535
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Surveillance of arbovirus infections in the Atlantic Forest Region, State of São Paulo, Brazil. I. Detection of hemagglutination-inhibiting antibodies in wild birds between 1978 and 1990.
    Ferreira IB; Pereira LE; Rocco IM; Marti AT; de Souza LT; Iversson LB
    Rev Inst Med Trop Sao Paulo; 1994; 36(3):265-74. PubMed ID: 7855491
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Arbovirus surveillance in Florida: wild vertebrate studies 1965-1974.
    Bigler WJ; Lassing E; Buff E; Lewis AL; Hoff GL
    J Wildl Dis; 1975 Jul; 11(3):348-56. PubMed ID: 1152173
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Humoral, mucosal, and cellular immunity in response to a human immunodeficiency virus type 1 immunogen expressed by a Venezuelan equine encephalitis virus vaccine vector.
    Caley IJ; Betts MR; Irlbeck DM; Davis NL; Swanstrom R; Frelinger JA; Johnston RE
    J Virol; 1997 Apr; 71(4):3031-8. PubMed ID: 9060663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.